A Novel Combination Therapy for Human Oxaliplatin-resistant Colorectal Cancer Using Oxaliplatin and Coxsackievirus A11
Beibei Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Kenzaburo Tani(Tokyo Medical University), Kazunari Yamada(Kyushu University Hospital), Mutsunori Murahashi(Jikei University School of Medicine), Hiroyuki Inoue(Fukuoka University), Yuto Takishima(Kyushu University), Shohei Miyamoto(Kyushu University), Hiroyuki Shimizu(University of the West Indies System), Hisanobu Ogata(Kyushu University), Yasuki Hijikata(Kyushu University Hospital), Yoichi Nakanishi(RIKEN Center for Integrative Medical Sciences), Toshihiko Okazaki(Johns Hopkins University), Masaki Kuroda(Kyushu University)
Cited by 18
Related Papers
Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19
|Nature Immunology|2020|1.4k
Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera
|Cell|2021|1.2k
SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses
|Cell|2022|1k
Antibody evasion by the P.1 strain of SARS-CoV-2
|Cell|2021|661